Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 37-41

  Begany, Diane P ^a   Carcillo, Joseph A ^a   Herzer, William A ^a   Mi, Zaichuan ^a   Jackson, Edwin K ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; CYCLIC AMP; ESCHERICHIA COLI ENDOTOXIN; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYCLIC AMP URINE LEVEL; ENDOTOXEMIA; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; URINE VOLUME;

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ANIMALS; BLOOD FLOW VELOCITY; ENDOTOXINS; KIDNEY FAILURE, ACUTE; MALE; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030437941     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BEAVO, J. A., CONTI, M. AND HEASLIP, R. J.: Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46: 399-405, 1994.
2. BEAVO, J. A. AND REIFSNYDER, D. H.: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. TIPS 11: 150-155, 1990.
3. CHINI, C. C., CHINI, E. N., WILLIAMS, J. M., MATOUSOVIC, K. AND DOUSA, T. P.: Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int. 46: 28-36, 1994.
4. CHURCHILL, P. C., BIDANI, A. K. AND SCHWARTZ, M. M.: Renal effects of endotoxin in the male rat. Am. J. Physiol. 253: F244-F250, 1987.
5. CONGER, J. D., FALK, S. A. AND GUGGENHEIM, S. J.: Glomerular dynamics and morphologic changes in the generalised Schwartzman reaction in post-partum rats. J. Clin. Invest. 67: 1334-1346, 1981.
6. DENT G., GIEMBYCZ, M. A., EVANS, P. M., RABE, K. F. AND BARNES, P. J.: Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibition of type IV phosphodiesterase: Interactions with beta-adrenergic agonist albuterol. J. Pharmacol. Exp. Ther. 271: 1167-1174, 1994.
7. FISCHER, W. SCHUDT, C. AND WENDEL, A.: Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosaminesensitized mice. Biochem. Pharmacol. 45: 2399-2404, 1993.
8. KIKERI, D., PENNELL, J. P., HWANG, K. H., JACOBS, A. I., RICHMAN, A. V. AND BOURGOIGNIE, J. J.: Endotoxemic acute renal failure in awake rats. Am. J. Physiol. 250: F1098-F1106, 1986.
9. 1 adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine on acute renal dysfunction induced by Escherichia coli endotoxin in rats. J. Pharm. Pharmacol. 45: 979-984, 1993.
10. MOLNAR-KIMBER, K., YONNO, L., HEASLIP, R. AND WEICHMAN, B.: Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 39: C77-C79, 1993.
11. MORRISON, D. C. AND RYAN, R. L.: Endotoxins and disease mechanisms. Annu. Rev. Med. 38: 417-432, 1987.
12. PRABHAKAR, U., LIPSHUTZ, D., BARTUS, J. O., SLIVJAK, M. J., SMITH, E. F. 3RD, LEE, J. C. AND ESSER, K. M.: Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol. 16: 805-816, 1994.
13. TURNEY, J. H., MARSHALL, D. H., BROWNJOHN, A. M., ELLIS, C. M. AND PARSONS, F. M.: The evolution of acute renal failure, 1956-1988. Q. J. Med. 74: 83-104, 1990.